Emigrating in the private space

The Lure of Capital

Although last week's merger between Xytis Pharmaceutical Ltd. and Remergent Inc. matches Xytis' clinical development capabilities with Remergent's discovery skills, the main goal for Europe-based Xytis was to access U.S. capital and establish a U.S. presence. ...